Small Cell Lung Cancer Prognosis After Recurrence

Lung cancer recurrence is generally defined as lung cancer that returns after treatment and following a period of more than three months of remission in which there is no evidence of the disease.

Small cell lung cancer prognosis after recurrence.

After someone is diagnosed with small cell lung cancer sclc doctors will try to figure out if it has spread and if so how far. A recurrence may be the same cancer type or occur in the same location as before or the type and location may be different. Relapse of stage i small cell lung cancer ten or more years after the. Relative survival rates for non small cell lung cancer nsclc.

Treatment for recurrent non small cell lung cancer japanese journal of clinical oncology. This process is called staging. It helps determine how serious the cancer is and how best to treat it. Each lung has sections called lobes the left lung has two lobes.

For women the number is about 112 350 a year. Almost 90 of lung cancers are this type. While progress has been made in the treatment of small cell lung cancer better treatment strategies are needed as many patients still experience disease recurrence. It can cause symptoms ranging from fatigue to coughing up blood and is more aggressive than the more common non small cell lung cancer nsclc smoking is the leading cause of sclc and a biopsy is needed to confirm a diagnosis while it may respond to radiation and chemotherapy initially sclc can spread.

When non small cell lung cancer nsclc has progressed or returned following an initial treatment with surgery radiation therapy and or chemotherapy it is said to be recurrent or relapsed. Small cell lung cancer sclc accounts for approximately 15 of all lung cancers. The lungs bring oxygen into the body when you breathe in and take out carbon dioxide when you breathe out. The national cancer institute s database breaks down the cancers by how far the tumors.

The stage of a cancer describes how much cancer is in the body. The lungs are a pair of cone shaped breathing organs that are found in the chest. Patients experiencing a recurrence of nsclc historically have had few treatment options. The progress that has been made in the treatment of small cell lung cancer has resulted from improved development of multi modality treatments and participation in clinical trials.